1984
DOI: 10.1016/0002-9343(84)90349-8
|View full text |Cite
|
Sign up to set email alerts
|

Folate metabolism and chromosomal stability in the fragile X syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
6
0

Year Published

1986
1986
1997
1997

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 20 publications
(7 citation statements)
references
References 25 publications
1
6
0
Order By: Relevance
“…The 3p14 and 16q23 sites were the most common autosomal locations for breaks in cells from both control and fragile X syndrome individuals. In conclusion our results with a relatively large sample of control and fragile X syndrome individuals confirmed earlier reports (Vekemans et al 1983;Branda et al 1984) that no increased chromosome breakage exists in the fragile X syndrome individuals compared with control subjects. …”
supporting
confidence: 92%
“…The 3p14 and 16q23 sites were the most common autosomal locations for breaks in cells from both control and fragile X syndrome individuals. In conclusion our results with a relatively large sample of control and fragile X syndrome individuals confirmed earlier reports (Vekemans et al 1983;Branda et al 1984) that no increased chromosome breakage exists in the fragile X syndrome individuals compared with control subjects. …”
supporting
confidence: 92%
“…Although others [Branda et al, 1984;Gregory et al, 19861 have shown similar overall SCE rates for fragile X males and controls, attempts to identify the X chromosome to look specifically at the Xq27 site were not made. Our analysis of SCE at Xq27 suggested a significant increase in fragile X male cells grown in deficient medium compared to all other subjects.…”
Section: Discussionmentioning
confidence: 99%
“…Clinically affected individuals can usually be diagnosed cytogenetically by an in vitro gap or break at Xq27 induced by media conditions that block the de novo thymidylic acid pathway (Sutherland 1979;Glover 1981;Tommerup et al 1981;Fonatsch 1981). However, there is no experimental evidence to suggest an in vivo defect in this biochemical pathway for fragile X subjects (Popovich et al 1983; Wang and Erbe 1984;Branda et al 1984).…”
Section: Indroductionmentioning
confidence: 99%